WebJul 11, 2024 · ROCKVILLE, Md., July 15, 2024 (GLOBE NEWSWIRE) -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics … WebThis section also highlights likely future developments in the market. Global Market Size and Growth: Global historic (2016-2024) and forecast (2024-2026), and ... Synthetic Biology …
Synthetic Biologics Inc. (SYN) Stock Price, News & Historical Data ...
WebJan 13, 2024 · Synthetic Biologics Inc. (SYN) shares closed today at 2.0% above its 52 week low of $0.26, giving the company a market cap of $36M. The stock is currently up 2.3% … WebAbout the Synthetic Biologics, Inc. stock forecast. As of 2024 March 31, Friday current price of SYN stock is 0.001$ and our data indicates that the asset price has been in a … is soft and comfy fabric same as minky
Synthetic Biologics - SYN Stock Forecast, Price & News
WebApr 13, 2024 · Theriva Biologics (NYSE American: TOVX), is a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need. The Company’s subsidiary Theriva Biologics, S.L., has been developing a new oncolytic adenovirus platform designed for intravenous (IV), intravitreal and ... WebSynthetic Biologics has a current Real Value of $1.25 per share. The regular price of the company is $1.02. Today, the company appears to be undervalued.Our model measures the value of Synthetic Biologics from inspecting the company fundamentals such as Return On Equity of (0.26) %, shares owned by institutions of 8.08 %, and Shares Outstanding of … is softarchive legit